Indication
Moderate to Severe Upper Face Lines
1 clinical trial
2 products
Clinical trial
A Phase Ib/II, Multicentre, Double-blind, Randomised, Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in Improving the Appearance of Moderate to Severe Upper Facial Lines in AdultsStatus: Recruiting, Estimated PCD: 2024-11-30
Product
IPN10200Product
Dysport